Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication

Journal of Virology

Volumn 77, Issue 7, 2003, Pages 3898-3912

  Wang, Chunfu ^a   Pflugheber, Jill ^a   Sumpter Jr , Rhea ^a   Sodora, Donald L ^b   Hui, Daniel ^c   Sen, Ganes C ^c   Gale Jr , Michael ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INITIATION FACTOR 2; INITIATION FACTOR 2ALPHA; NONSTRUCTURAL PROTEIN 5A; PROTEIN KINASE; PROTEIN KINASE R; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; DISSOCIATION; FRACTIONATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; POLYSOME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN SYNTHESIS; REPLICON; RNA REPLICATION; TRANSLATION INITIATION; TRANSLATION REGULATION; VIRUS REPLICATION;

BASE SEQUENCE; CARRIER PROTEINS; CELL LINE; DNA, VIRAL; DRUG STABILITY; EIF-2 KINASE; ENZYME INHIBITORS; EUKARYOTIC INITIATION FACTOR-2; HEPACIVIRUS; HUMANS; INTERFERON ALFA-2A; MODELS, BIOLOGICAL; POLYRIBOSOMES; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPLICON; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 0037379437     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.7.3898-3912.2003     Document Type: Article

References (58)

1. Alter, M. J., D. Kruszon-Moran, O. V. Nainan, G. M. Mcquillan, F. Gao, L. A. Moyer, R. A. Kaslow, and H. S. Margolis. 1999. The prevelance of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 314:556-562.
2. Alter, M. J. H. 1997. Epidemiology of hepatitis C. Hepatology 26:62-65.
3. Asano, K., W. Merrick, and J. Hershey. 1997. The translation initiation factor eIF3-p48 subunit is encoded by int-6, a site of frequent integration by the mouse mammary tumor virus genome. J. Biol. Chem. 272:23477-23480.
4. Baron, S., S. K. Tyring, W. R. Fleischmann, Jr., D. H. Coppenhaver, D. W. Niesel, G. R. Klimpel, G. J. Stanton, and T. K. Hughes. 1991. The interferons: mechanisms of action and clinical applications. J. Am. Med. Assoc. 266:1375-1383.
5. Blight, K. J., A. A. Kolykhalov, and C. M. Rice. 2000. Efficient inititation of HCV RNA replication in cell culture. Science 290:1972-1974.
6. Clemens, M. J., and A. Elia. 1997. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17:503-524.
7. Donzé, O., R. Jagus, A. E. Koromilas, J. W. B. Hershey, and N. Sonenberg. 1995. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 14:3828-3834.
8. Fredericksen, B., G. Akkaraju, E. Foy, C. Wang, J. Pflugheber, Z. J. Chen, and M. Gale, Jr. 2001. Activation of the interferon-β promoter during hepatitis C virus RNA replication. Viral Immunol. 15:29-40.
9. Gale, M., Jr., C. M. Blakely, B. Kwieciszewski, S.-L. Tan, M. Dossett, M. J. Korth, S. J. Polyak, D. R. Gretch, and M. G. Katze. 1998. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol. Cell. Biol. 18:5208-5218.
10. Gale, M., Jr., and M. G. Katze. 1997. What happens inside lentivirus or influenza virus infected cells: insights into regulation of cellular and viral protein synthesis. Methods Companion Methods Enzymol. 11:383-401.
11. Gale, M., Jr., and M. G. Katze. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78:29-46.
12. Gale, M., Jr., B. Kwieciszewski, M. Dossett, H. Nakao, and M. G. Katze. 1999. Anti-apoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J. Virol. 73:6506-6516.
13. Gale, M., Jr., S.-L. Tan, and M. G. Katze. 1999, Translational control of viral gene expression in eukaryotes. Microbiol. Mol. Biol. Rev. 64:239-280.
14. Geiss, G. K., G. Jin, J. Guo, R. E. Bumgarner, M. G. Katze, and G. C. Sen. 2001. A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J. Biol. Chem. 276:30178-30182.
15. Girard, S., P. Shalhoub, P. Lescure, A. Sabile, D. Misek, S. Hanash, C. Brechot, and L. Beretta. 2002. An altered cellular response to interferon and upregulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 295:272-283.
16. Goodbourn, S., L. Didcock, and R. E. Randall. 2000. Interferons: cell signaling, immune modulation, antiviral responses and virus countermeasures, J. Gen. Virol. 81:2341-2364.
17. Guo, J., V. Bichko, and C. Seeger. 2001. Effect of alpha interferon on the hepatitis C virus replication. J. Virol. 75:8516-8523.
18. Guo, J., D. J. Hui, W. C. Merrick, and G. C. Sen. 2000. A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J. 19:6891-6899.
19. Guo, J., K. L. Peters, and G. C. Sen. 2000. Induction of the human protein p56 by interferon, double-stranded RNA, or virus infection. Virology 267:209-219.
20. He, Y., S.-L. Tan, S. U. Tareen, S. Viyasri, J. O. Langland, B. Jacobs, and M. G. Katze. 2001. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A. J. Virol. 75:5090-5098.
21. Honda, M., S. Kaneko, E. Matsushita, K. Kobayashi, G. Abell, and S. M. Lemon. 2000. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 118:152-162.
22. Kaneko, T., Y. Tanji, S. Satoh, M. Hijikata, S. Asabe, K. Kimura, and K. Shimotohno. 1994. Production of two phosphoproteins from the NS5A region of the heptatitis C viral genome. Biochem. Biophys. Res. Commun. 205:320-326.
23. Kato, J., N. Kato, M. Moriyama, T. Goto, H. Taniguchi, Y. Shiratori, and M. Omata. 2002. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activiated protein kinase-independent pathway. J. Infect. Dis. 186:155-163.
24. Katze, M. G., Y. He, and M. Gale, Jr. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:675-677.
25. r protein kinase in a cell-free system. Mol. Cell. Biol. 11:5497-5505.
26. Kawagishi-Kobayashi, M., J. B. Silverman, T. L. Ung, and T. E. Dever. 1997. Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF-2α. Mol. Cell. Biol. 17:4146-4158.
27. Kieft, J. S., K. Zhou, R. Jubin, and J. A. Doudna. 2001. Mechanism of ribosome recruitment by hepatitis C IRES RNA. RNA 7:194-206.
28. Koev, G., R. Duncan, and M. M. C. Lai. 2002. Hepatitis C virus IRES-dependent translation is insensitive to an eIF2α-independent mechanisms of inhibition by interferon in hepatocyte cell lines. Virology 297:195-202.
29. Kreiger, N., V. Lohmann, and R. Bartenschlager. 2001. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol. 75:4614-4654.
30. r protein and their use for the detection of double-stranded RNA dependent protein kinase in human cells. Proc. Natl. Acad. Sci. USA 82:4341-4345.
31. Leib, D. A., M. A. Machalek, B. R. G. Williams, R. H. Silverman, and H. W. Virgin. 2000. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Natl. Acad. Sci. USA 97:6097-6101.
32. Lindsay, K. L. 1997. Therapy of hepatitis C: an overview. Hepatology 26:71S-77S.
33. Lohmann, V., F. Korner, J.-O. Kock, L. Theilmann, and R. Bartenschlager. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113.
34. Martell, M., J. Gomez, J. I. Esteban, S. Sauleda, J. Quer, B. Cabot, R. Esteban, and J. Guardia. 1999. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J. Clin. Microbiol. 37:327-332.
35. Merrick, W. C., and J. W. B. Hershey. 1996. The pathway and mechanism of eukaryotic protein synthesis, p. 31-70. In J. Hershey, M. Mathews, and N. Sonenberg (ed.), Translational control. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
36. Neumann, A. U., N. P. Lam, H. Dahari, D. R. Gretch, T. E. Wiley, T. J. Layden, and A. S. Perelson. 1999. Hepatitis C virus dynamic in vivo and the antiviral efficacy of interferon-α therapy. Science 282:103-107.
37. Noguchi, T., S. Satoh, T. Noshi, E. Hatada, R. Fukuda, A. Kawai, S. Ikeda, M. Hijikata, and K. Shimotohno. 2001. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells. Microbiol. Immunol. 45:829-840.
38. Pawlotsky, J.-M. 2000. Hepatitis C virus resistance to antiviral therapy. Hepatology 32:889-896.
39. Pestova, T. V., V. G. Kolupaeva, I. B. Lomakin, E. V. Pilipenko, I. N. Shatsky, V. I. Agol, and C. U. T. Hellen. 2001. Molecular mechanisms of translation initiation in eukaryotes. Proc. Natl. Acad. Sci. USA 98:7029-7036.
40. Pflugheber, J., B. Fredericksen, R. Sumpter, C. Wang, F. Ware, D. Sodora, and M. J. Gale. 2002. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication. Proc. Natl. Acad. Sci. USA 99:4650-4655.
41. Pietschmann, T., V. Lohmann, G. Rutter, K. Kurpanek, and R. Bartenschlager. 2001. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J. Virol. 75:1252-1264.
42. Pitha, P. M. 1994. Multiple effects of interferon on the replication of human immunodeficiency virus type 1. Antiviral Res. 24:205-219.
43. Polyak, S. J., K. Khabar, D. Paschal, H. Ezelle, G. Duverlie, G. Barber, D. Levy, N. Mukaida, and D. Gretch. 2001. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J. Virol. 75:6095-6106.
44. Reed, K. E., and C. M. Rice. 1998. Molecular characterization of hepatitis C virus, p. 1-37. In H. W. Reesink (ed.), Hepatitis C virus, vol. 1. Karger, Basel, Switzerland.
45. Reed, K. E., J. Xu, and C. M. Rice. 1997. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. J. Virol. 71:7187-7197.
46. Ruan, H., C. Y. Brown, and D. R. Morris. 1997. Analysis of ribosome loading onto mRNA species: implications for translational control, p. 305-321. In J. D. Richter (ed.), mRNA formation and function. Academic Press, Inc., New York, N.Y.
47. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
48. Sen, G. C., and R. M. Ransohoff. 1993. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42:57-102.
49. Shimazaki, T., M. Honda, S. Kaneko, and K. Kobayashi. 2002. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein. Hepatology 35:199-208.
50. Silverman, R. H. 1994. Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action. J. Interferon Res. 14:101-104.
51. Sizova, D. V., V. G. Kolupaeva, T. V. Pestova, I. N. Shatsky, and C. T. Hellen. 1998. Specific interaction of eukaryotic translation initiation factor 3 with the 5′ nontranslated regions of hepatitis C virus and classical swine fever virus RNAs. J. Virol. 72:4775-4782.
52. Taha, C., Z. Liu, J. Jin, H. Al-Hasani, N. Sonenberg, and A. Klip. 1999. Opposite translational control of GLUT1 and GLUT4 glucose transporter mRNAs in response to insulin. J. Biol. Chem. 274:33085-33091.
53. Tan, S.-L., and M. G. Katze. 2001. How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology 284:1-12.
54. Taylor, D. R., S. T. Shi, P. R. Romano, G. N. Barber, and M. M. C. Lai. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285:107-110.
55. Thomis, D. C., and C. E. Samuel. 1992. Mechanism of interferon action: autoregulation of RNA-dependent PI/eIF-2 alpha protein kinase (PKR) expression in the transfected mammalian cells. Proc. Natl. Acad. Sci. USA 89:10837-10841.
56. Witherell, G. W., and P. Belbeke. 2000. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63:8-16.
57. Yeung, M. C., D. L. Chang, R. E. Camantigue, and A. S. Lau. 1999. Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells. Proc. Natl. Acad. Sci. USA 96:11860-11865.
58. Young, K., R. Resnick, and T. Myers. 1993. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J. Clin. Microbiol. 31:882-886.